Gynecologic Cancer
News
Screening Does Not Reduce Ovarian Cancer Mortality
Major Finding: Among women who underwent screening with the CA 125 blood test and transvaginal ultrasound, 118 died of ovarian cancer, whereas 100...
News
Antiviral Cidofovir May Enhance Therapies for HPV-Related Cancers
Major Finding: Cidofovir appears to increase the sensitivity of cervical carcinomas to the effects of radiotherapy and chemotherapy.
News
PARP Inhibitor Olaparib Delays Progression in Ovarian Cancer
Major Finding:Maintenance therapy with olaparib extended progression-free survival to 8.4 months vs. 4.8 months with placebo. Data Source:...
News
Three-Year Interval Safe for Cervical Cancer Screening after Negative HPV Test
Major Finding: The 5-year risk of cancer with a negative HPV test and a negative Pap smear was 3.2/100,000 women per year, but the difference...
News
Gynecologic Cancer Symptoms May Be More Severe in Women With Psychiatric Histories
Major Finding: In a broad sampling of women with gynecologic cancer both on and off treatment, 32% reported clinically significant pain; 32%,...
News
BRCA2 Gene Mutation Linked With Improved Survival in Ovarian Cancer
Major Finding: The 5-year survival was 36% in those with no BRCA mutation, 46% in those with the BRCA1 mutation, and 61% in those with the BRCA2...
News
Fewer Than Half of Ovarian Cancer Patients Get Care Consistent with NCCN Guidelines
Major Finding: Care consistent with National Comprehensive Cancer Care guidelines was provided to 43% of 96,802 women with ovarian cancer.Data...
Research
Symptom Experience in Patients with Gynecological Cancers: The Development of Symptom Clusters through Patient Narratives
News
Half of HIV+ Women in Zambia Positive for Cervical Cancer
Major Finding: 54% of 6,572 HIV-infected women in Zambia screened positive for cervical cancer.Data Source: Study of 20,010 women who were...
News
Bevacizumab Doubles Risk of GI Adverse Events in Key Ovarian Cancer Trial
Major Finding: GI adverse events occurred in 1.7% women who were treated only with standard therapies, compared with 3.4% of the two bevacizumab...
News
Optimal Therapy Elusive for Many Ovarian Cancer Patients With Medicare
Major Finding: Thirty-nine percent of women with advanced ovarian cancer in the Medicare population receive recommended first-line combination of...